Piscataway, NJ, United States of America

Melissa Dumble

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Collegeville, PA (US) (2014 - 2015)
  • Piscataway, NJ (US) (2014 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Melissa Dumble: Innovator in Cancer Treatment

Introduction

Melissa Dumble is a prominent inventor based in Piscataway, NJ (US), known for her significant contributions to cancer treatment through innovative pharmaceutical combinations. With a total of five patents to her name, she has made strides in developing methods that target specific pathways in cancer cells.

Latest Patents

One of her latest patents focuses on a combination of an inhibitor of B-Raf and an inhibitor of AKT in the treatment of cancer. This invention relates to a method of treating cancer in humans, utilizing specific pharmaceutical combinations to enhance treatment efficacy. Another notable patent involves a novel combination of a MEK inhibitor and B-Raf inhibitors, which aims to provide therapeutic benefits in conditions where the inhibition of these pathways is crucial, particularly in cancer.

Career Highlights

Throughout her career, Melissa has worked with leading pharmaceutical companies, including GlaxoSmithKline LLC and Novartis AG. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry, furthering her research and development efforts.

Collaborations

Some of her notable coworkers include Rakesh Kumar and Sylvie Laquerre, who have contributed to her projects and innovations in the field of cancer treatment.

Conclusion

Melissa Dumble's work exemplifies the impact of innovative thinking in the pharmaceutical industry, particularly in the fight against cancer. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…